ArisGlobal Events

Proventa International Roundtable Webinars

May 11, 2021

Small exclusive Safety executive leaders who face strategic challenges are brought together in this rountable 60-minute webinar discussions. Enables participants to share ideas and lessons learned. Facilitated by ArisGlobal thought leaders, these sessions provide a valuable dialogue over challenges and topical issues. Each roundtable discussion group has a mix of CxO, VP and Director-level individuals which ensures each delegate is given ample opportunity to raise questions and contribute from a strategic perspective.

Transitioning from Medical Information to Medical Intelligence

May 19, 2021

In “Transitioning from Medical Information to Medical Intelligence”, Sandeep Mahagaonkar, Sr. Director, Medical Affairs and Quality Product Management at ArisGlobal, shares his knowledge and expertise on the trends shaping the MI automation space and how medical information teams can be better equipped with new and emerging technologies in business process automation.

IDMP, Key Engine to a Regulatory Strategy

May 20, 2021 at 11:00am EST

Regulatory Departments at EU life science companies are finally gearing up for IDMP implementation after years of policy development. IDMP can be considered a framework for investing in the processes and technology to not only achieve compliance, but to also address the end-to-end processes throughout the regulatory lifecycle. Thinking about IDMP from the beginning of your team’s process will avoid costly delays and achieve full compliance that is also scalable and ready for future growth. IDMP compliance is a timely springboard to address your larger regulatory strategy. We’ll also discuss what investments are needed as we look forward to the future of automation and AI improvements that help simplify compliance processes and bring a new level of innovation to geographically diverse regulatory teams.Please join us on May 20.

Decentralized Clinical Trials – Collaboration Urgency Grows

May 25, 2021 at 11:00am EST

When Covid-19 hit, the concept of decentralized trials suddenly switched from nice idea to necessity. The urgency of the pandemic pushed decentralization to center stage.

During this panel discussion with a case study and Q&A, we will consider:

• What percentage of current trials are decentralized?
• How has decentralization changed the nature of collaboration among clinical research partners?
• What are your primary concerns about putting decentralized trials into operation?
• How will regulatory authorities respond if more studies add decentralized features?

R&G PharmaStudies Webinar

August 18, 2021

China’s GVP was recently announced and once implemented on December 1st this year, there will be more stringent and specific requirements for post-market safety monitoring. There are multiple modes of post-market safety monitoring, such as the traditional clinical trial-oriented mode, supplementary trials required by CDE, large-scale epidemiological investigations, specially designed IIT and its combination, retrospective research featuring big data, etc., They are inseparable from the pharmacovigilance system.

Webinar Date and Time: August 18, 2021 at 9:30 am China Standard Time

RAPS Convergence 2021 | RAPS – Virtual Exibition and Speaker Slot

September 12 – 15, 2021

RAPS Convergence is the largest and most well-recognized annual gathering of regulatory professionals, scientists, and innovators in the world. Convergence brings together representatives from industry, global regulatory bodies, and research, academic and clinical organizations that are directly involved in managing the regulatory process and aligning science, regulation, and business strategy.

Convergence is designed to educate and empower professionals about the ever-evolving healthcare product regulatory environment within an interactive forum that facilitates community exchange, connections and knowledge sharing.

Breakthrough2021

September 21 – 22, 2021 – Watch Now On-Demand

ArisGlobal’s Breakthrough2021 is a virtual event that gathers key members of the life sciences and digital health community to provide insights into innovation, AI and digital transformation. This year’s event will feature sessions and keynotes by leading voices from across the industry, aimed at sharing ideas, experiences, and best practices.

Highlights:

• Listen to leading voices in life sciences across two days of thought-provoking conversations
• Learn directly from ArisGlobal customers and product leaders as they share R&D technology best practices and successes
• Access an on-demand library of exclusive, industry-specific content
• Complimentary attendance for members of the life sciences industry

Word Drug Safety Congress Europe 2021

October 6 – 7, 2021

Europe’s Most Exciting Drug Safety & PV EventThe World Drug Safety Congress Europe will bring together drug safety, pharmacovigilance, data analytics, epidemiology, and other key players in the biopharma sector. Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. Join us in Amsterdam.

Location: Amsterdam, Netherlands

Hilton Amsterdam: Apollolaan 138, 1077 BG Amsterdam, Netherlands

Phone: +31 20 710 6000

Word Drug Safety US 2021

October 20 – 21, 2021

The World Drug Safety Congress Americas will bring together 600+ top leaders and stakeholders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety. Explore strategies in data management & signal detection, showcase how AI & machine learning have improved PV processes, discuss the challenges creating a PV strategy for advanced therapies, and collaborate on medical device safety strategies. This conference is the largest commercial gathering of PV professionals in the world.

Location: Boston, MA

Westin Boston Seaport District: 425 Summer St, Boston, MA 02210

Phone: (617) 532-4600

Hotel: To be booked by ArisGlobal travel desk. Booking link: https://book.passkey.com/e/50172363

TMF Summit

October 25 – 27, 2021

The Trial Master File Summit has been the cornerstone event in Clinical Document Management since its inception 10 years ago.

This year’s conference program is guided by our esteemed advisory board and will continue upon its legacy of providing the TMF community with actionable strategies and useful tools needed to return to work informed, equipped, and inspired to guide their organization’s TMF to its full potential! Join our TMF community to experience the education, collaboration, and networking that can only be experienced at the Summit!

Location: New Orleans

Proventa Clinical Ops East Coast

November 2, 2021

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s Clinical Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Clinical Operations professionals from across the West Coast in San Francisco, to discover new insights and take your company’s mission to the next level.

Proventa Clinical Ops West Coast

November 17, 2021

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s Clinical Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Clinical Operations professionals from across the West Coast in San Francisco, to discover new insights and take your company’s mission to the next level.

Pharmacovigilance World 2021 | Pharmaceutical Conference

November 23 – 24, 2021

With the augmented incidence of diseases, and the non-medical use of prescription drugs, the incidence of drug abuse has increased enormously in the recent years, which is apparent with the excess documentation of adversities and drug toxicities. In this context, the drug safety and pharmacovigilance has emerged as a dynamic clinical and scientific discipline to provide adequate information and ensure health safety by the joint interaction of doctors and patients in choosing appropriate treatment method and drug. However, evidences suggest though avoidable, the adverse drug reactions (ADRs) to medicines continue to be the bigger life risk. In England, ADR was responsible for up to 6% of hospital admissions, carrying a mortality of 2% and costing the NHS £466 million per annum (€654 million, US$ 602 million) in 2004. In some countries, ADR is ranked among the top 10 leading cause of mortality.